In the present study, we aimed to perform a comprehensive analysis of the BCR repertoire, which is the genetic source of neutralizing antibodies (nAbs) [16], in COVID-19 patients that underwent ECMO using a single-cell approach. Here, BCR is linked to COVID-19.